Candriam S.C.A. - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 23 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2021$1,992,000
-4.0%
1,9000.0%0.02%
+6.2%
Q4 2020$2,074,000
-4.3%
1,900
-9.5%
0.02%
-20.0%
Q3 2020$2,167,000
-6.6%
2,1000.0%0.02%
-16.7%
Q2 2020$2,320,000
-5.9%
2,100
-4.5%
0.02%
-11.1%
Q1 2020$2,465,000
-2.3%
2,2000.0%0.03%0.0%
Q4 2019$2,522,000
+85.9%
2,200
+120.0%
0.03%
+58.8%
Q1 2019$1,357,000
+25.9%
1,0000.0%0.02%0.0%
Q4 2018$1,078,000
+2.1%
1,0000.0%0.02%
+21.4%
Q3 2018$1,056,000
+7.5%
1,0000.0%0.01%
-12.5%
Q2 2018$982,0001,0000.02%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2021
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 73,641,000$58,038,0004.94%
STEELHEAD PARTNERS LLC 52,496,000$62,306,0004.87%
SILVERBACK ASSET MANAGEMENT LLC 25,000,000$29,656,0004.56%
Castle Creek Arbitrage, LLC 10,734,000$12,733,0003.32%
TENOR CAPITAL MANAGEMENT Co., L.P. 40,132,000$47,726,0002.41%
Sonora Investment Management, LLC 17,232,000$20,380,0002.28%
TORONTO DOMINION BANK 1,000,002$5,947,335,0001.84%
TFG Asset Management GP Ltd 8,500,000$10,084,0001.46%
SYMPHONY ASSET MANAGEMENT LLC 5,000,000$5,925,0001.24%
SSI INVESTMENT MANAGEMENT LLC 13,441,000$15,893,0001.18%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders